ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 95 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $10,358,000 | -12.5% | 433,585 | 0.0% | 0.46% | -9.2% |
| Q2 2021 | $11,833,000 | -45.1% | 433,585 | -41.8% | 0.51% | -32.4% |
| Q1 2021 | $21,535,000 | -11.7% | 744,370 | -14.2% | 0.76% | -30.5% |
| Q4 2020 | $24,393,000 | -25.2% | 867,170 | -22.1% | 1.09% | -42.2% |
| Q3 2020 | $32,619,000 | -16.3% | 1,113,265 | -13.7% | 1.88% | -32.6% |
| Q2 2020 | $38,990,000 | -22.4% | 1,289,360 | -23.5% | 2.80% | -38.6% |
| Q1 2020 | $50,259,000 | – | 1,686,527 | – | 4.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,684,232 | $46,113,272 | 3.06% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,105,309 | $5,869,191 | 2.34% |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $15,930,000 | 1.78% |
| Sio Capital Management, LLC | 635,969 | $3,376,995 | 1.04% |
| Rubric Capital Management LP | 5,034,530 | $26,733,354 | 1.00% |
| Tejara Capital Ltd | 309,179 | $1,641,740 | 0.93% |
| AlphaCentric Advisors LLC | 165,000 | $876,150 | 0.50% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,135,227 | $6,028,055 | 0.33% |
| Orbimed Advisors | 1,914,479 | $10,165,883 | 0.22% |
| Two Seas Capital LP | 164,807 | $875,125 | 0.18% |